ORGANOPlus connects human-derived organ-mimetic technology with data-driven analysis to build a next-generation Human Validation platform that supports decision-making in drug development.
ORGANOPlus is a Human Validation platform company opening new possibilities in drug development with its proprietary organ-on-a-chip technology and data-driven analysis.
Oncology & Immunotherapy
Tumor and immune response validation platform
Gut & Microbiome
Gut and microbiome validation platform
Multi-Organ Systems
Multi-organ linked validation platform
Through scientific innovation and global ambition, we broaden the possibilities for better drug development.
From our Korean hubs and Danish entity, we expand our validation infrastructure with global research institutes and pharma partners.
Chuncheon, Gangwon-do
Gangnam-gu, Seoul
European business hub
Cardiac tissue/cell-based organ toxicity prediction models
Advanced research on VILLIORGAN™ membrane structure and cell culture performance
European business infrastructure with local partners and government support programs
